A practical benchmark from Mayo Clinic: clinicians often reassess whether a weight-loss medication is working after 3-6 months at the full dose (or the best-tolerated dose), aiming for meaningful progress like ~5% weight loss
Hypothalamic PPAR has been shown to play a role in the regulation of appetite, presumably via enhanced expression of MCD, with the use of pirinixic acid which is a PPAR agonist
Semaglutide is a GLP-1 agonist that activates one receptor
Patients should contact their healthcare provider immediately if they experience: Suicidal thoughts or self-harm ideation Call or text 988 Suicide & Crisis Lifeline, call 911, or go to the nearest emergency room if in immediate danger Severe depression lasting more than two weeks, particularly with loss of interest in previously enjoyed activities Panic attacks or sudden onset of severe anxiety interfering with daily function Significant mood swings that disrupt relationships, work performance, or quality of life Unusual behavioral changes noticed by family members or friends Worsening of pre-existing psychiatric conditions despite stable prior treatment Additionally, mood changes accompanied by other concerning symptoms require evaluation
[Crossref] [PubMed] Grech O, Mitchell JL, Lyons HS, et al
